| Product Code: ETC9937734 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Antithrombotic Drugs Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Antithrombotic Drugs Market - Industry Life Cycle |
3.4 United Kingdom (UK) Antithrombotic Drugs Market - Porter's Five Forces |
3.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Antithrombotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases and related conditions in the UK |
4.2.2 Growing aging population leading to higher demand for antithrombotic drugs |
4.2.3 Technological advancements in drug delivery systems and treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 High competition among market players leading to pricing pressures |
4.3.3 Potential adverse effects and risks associated with antithrombotic drugs |
5 United Kingdom (UK) Antithrombotic Drugs Market Trends |
6 United Kingdom (UK) Antithrombotic Drugs Market, By Types |
6.1 United Kingdom (UK) Antithrombotic Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Apixaban, 2021- 2031F |
6.1.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Debigatran, 2021- 2031F |
6.1.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Edoxaban, 2021- 2031F |
6.1.6 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Fondaparinux, 2021- 2031F |
6.1.7 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Heparin, 2021- 2031F |
6.1.8 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Rivaroxaban, 2021- 2031F |
6.2 United Kingdom (UK) Antithrombotic Drugs Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Thrombolytic Drugs, 2021- 2031F |
6.2.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Anti-Platelet Drugs, 2021- 2031F |
6.2.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Anticoagulants, 2021- 2031F |
6.2.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Antithrombotic Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.3.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Stroke, 2021- 2031F |
6.3.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Deep vein thrombosis (DVT), 2021- 2031F |
6.3.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Pulmonary Embolism (PE), 2021- 2031F |
6.3.6 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Antithrombotic Drugs Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United Kingdom (UK) Antithrombotic Drugs Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Kingdom (UK) Antithrombotic Drugs Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.5 United Kingdom (UK) Antithrombotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United Kingdom (UK) Antithrombotic Drugs Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Antithrombotic Drugs Market Export to Major Countries |
7.2 United Kingdom (UK) Antithrombotic Drugs Market Imports from Major Countries |
8 United Kingdom (UK) Antithrombotic Drugs Market Key Performance Indicators |
8.1 Number of new antithrombotic drug approvals in the UK market |
8.2 Patient adherence rates to antithrombotic drug therapies |
8.3 Rate of hospital readmissions due to thrombotic events |
9 United Kingdom (UK) Antithrombotic Drugs Market - Opportunity Assessment |
9.1 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 United Kingdom (UK) Antithrombotic Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Antithrombotic Drugs Market - Competitive Landscape |
10.1 United Kingdom (UK) Antithrombotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Antithrombotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here